KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 24.44K

Day Range

- - -

52 Wk Range

0.17 - 0.57

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

5.5

Recent Kintor Pharmaceutical Ltd News

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours.

Shanthi Rexaline

Kintor Pharmaceutical Announced Proxalutamide (GT0918) COVID-19 Clinical Trial Showed Positive Preliminary Results in Treatment of Female Patients

Kintor Pharmaceutical Limited (OTC:KNTPF) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr. Andy Goren and Dr. Flávio Adsuara Cadegiani, shows promising results in the treatment of COVID-19 female outpatients.

Charles Gross

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-169.74M

Investing Cash Flow (TTM)

14.41M

Financing Cash Flow (TTM)

40.27M

Free Cash Flow (TTM)

-170.48M

Capital Expenditure (TTM)

-742.00K

Net Change in Cash (TTM)

-115.06M

Valuation Metrics

Enterprise Value

$134.77M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

9.86

PB Ratio (TTM)

7.40

Earnings Yield % (TTM)

-24.69%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.03

Company Debt

Total Debt

$85.00M

LT Debt

LT Debt Issuance (TTM)

$116.39M

LT Debt Repayment (TTM)

-$163.15M

Total Cash

$32.74M

Debt to Equity

1.22

Issuance of Debt (TTM)

-$46.76M

Repayment of Debt (TTM)

-$163.15M

Key Statistics

Open

Volume / Avg.

0 / 24.44K

Day Range

- - -

52 Wk Range

0.17 - 0.57

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

5.5

About

Sector

Health Care

Industry

Biotechnology

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China, focusing on developing therapeutic drugs for unmet medical needs. Its pipelines cover indications of dermatology, such as AGA and acne vulgaris, and indications of tumors, c...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

KNTPF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

KNTPF

FAQ

How do I buy KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) stock?

You can purchase shares of KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (OTCPK:KNTPF) through any online brokerage.

View our list of the best stock brokerages

Who are KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) competitors?

There are no as such competitors for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD..

What is the forecast, or price target, for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) stock?

There is no analysis for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. to provide a consensus price target.

What is the current price for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF)?

The stock price for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (OTCPK: KNTPF) is $0.2415 last updated September 16, 2026 at 9:30 AM EDT.

Does KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) pay a dividend?

There are no upcoming dividends for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD..

When is KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (OTCPK:KNTPF) reporting earnings?

KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. does not have any upcoming earnings scheduled.

Is KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) going to split?

There is no upcoming split for KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD..

What sector and industry does KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. (KNTPF) operate in?

KINTOR PHARMACEUTICAL by KINTOR PHARMACEUTICAL LTD. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.